This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sanz MA . Cord-blood transplantation in patients with leukemia—a real alternative for adults. N Engl J Med 2004; 351: 2328–2330.
Rocha V, Gluckman E . Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft and transplantation related factors. Eurocord-Netcord registry and European Blood and Marrow Transplant Group. Br J Haematol 2009; 147: 262–274.
Fernández MN . Improving the outcome of cord blood transplantation: use of mobilized HSC and other cells from third party donors. Review. Br J Haematol 2009; 147: 161–176.
Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 2009; 15: 1628–1633.
Gluckman E, Rocha V . Donor selection for unrelated cord blood transplants. Curr Opin Immunol 2006; 18: 565–570.
Miller AN, Glode A, Hogan KR, Schaub C, Kramer C, Stuart RK et al. Efficacy and safety of ciprofloxacin for prophylaxis of polyoma BK virus-associated hemorrhagic cystitis in allogeneic hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant 2011; 17: 1176–1181.
Kwon M, Balsalobre P, Serrano D, Perez Corral A, Buño I, Anguita J et al. Single cord blood combined with HLA-mismatched third party donor cells: comparable results to matched unrelated donor transplantation in high-risk patients with hematologic disorders. Biol Blood Marrow Transplant 2013; 19: 143–149.
Liu H, Rich ES, Godley L, Odenike O, Joseph L, Marino S et al. Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions. Blood 2011; 118: 6438–6445.
Childs RW . Combined cord blood and haploidentical CD34+ cell transplantation improves transplant outcome for patients with treatment-refractory severe aplastic anemia [abstract]. 10th International Cord Blood Symposium 36, 2012 Available at http://www.cordbloodsymposium.org/.
Lindemans CA, Kuball JHE, te Boome LCJ, Versluys AB, Bierings MB, Boelens JJ . Coinfusion of haploidentical donor stem cells with unrelated cord blood[abstract]. 10th International Cord Blood Symposium 5, 2012 Available at http://www.cordbloodsymposium.org/.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
All authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Sánchez-Ortega, I., Arnan, M., Patiño, B. et al. Early engraftment and full-donor chimerism after single-cord blood plus third-party donor dual transplantation in patients with high-risk acute leukemia. Bone Marrow Transplant 49, 145–147 (2014). https://doi.org/10.1038/bmt.2013.113
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2013.113
This article is cited by
-
Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015
Bone Marrow Transplantation (2015)